Cumberland Pharmaceuticals (CPIX) Gross Profit (2016 - 2026)
Cumberland Pharmaceuticals' Gross Profit history spans 16 years, with the latest figure at -$993639.0 for Q4 2025.
- On a quarterly basis, Gross Profit rose 49.76% to -$993639.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $25.4 million, a 21.96% increase, with the full-year FY2025 number at $25.4 million, up 21.96% from a year prior.
- Gross Profit hit -$993639.0 in Q4 2025 for Cumberland Pharmaceuticals, down from $7.3 million in the prior quarter.
- Over the last five years, Gross Profit for CPIX hit a ceiling of $13.3 million in Q4 2022 and a floor of -$2.0 million in Q4 2024.
- Historically, Gross Profit has averaged $6.6 million across 5 years, with a median of $6.8 million in 2021.
- Biggest five-year swings in Gross Profit: skyrocketed 165.0% in 2022 and later tumbled 125.28% in 2024.
- Tracing CPIX's Gross Profit over 5 years: stood at $5.0 million in 2021, then skyrocketed by 165.0% to $13.3 million in 2022, then plummeted by 41.12% to $7.8 million in 2023, then tumbled by 125.28% to -$2.0 million in 2024, then soared by 49.76% to -$993639.0 in 2025.
- Business Quant data shows Gross Profit for CPIX at -$993639.0 in Q4 2025, $7.3 million in Q3 2025, and $8.8 million in Q2 2025.